Research powered investment banking
Home
Research
Companies
Find Alpha
Themes
Top Picks
Premium
Transactions
Events
Redeye
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Members network
Community
sign in
Log in
Sign up
Home
research
Companies
Find Alpha
Themes
Top Picks
Transactions
Events
redeye
About
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Community
The latest from Redeye about Scandinavian Life Science and Technology companies
Senzime
Direct sales model in Germany
Alzinova
Another external validation
PiezoMotor Uppsala
Progress in cell phone business project
Flexion Mobile
The Growth Journey Continues
Xspray Pharma
Brief Comment on Today’s Results
Sensys Gatso Group
Quick Comment Regarding the Investigation
Hexatronic Group
Q4’20: Solid beat in preliminary numbers
Acarix
Promising preliminary results
InDex Pharmaceuticals
Initial take on financing terms
Nanexa
Focus on Lenalidomide in New In-House Project ”NEX 20”
BioArctic
Validation of the amyloid-beta hypothesis
Enlabs
In the Wait for the Raise
Hansa Biopharma
2021 – första året på marknad
Smart Eye
Another Massive Downplayed Contract
Medivir
Intervju med vd Yilmaz Mahshid (video)
Nanexa
First Part of Investment Agreement Completed